Category Archives: News

FIRALIS : The Korean & Japanese market

FIRALIS, a high-tech company specialized in precision medicine and biotechnology. For more than 10 years, this biotech has been developing and commercializing diagnostic products that improve the management of disease in patients and therapeutic decisions, through the discovery and development of biomarkers , with a direct impact for better results incluiding comfort in patients and…
Read more

Firalis contribute to the Pacific CONSORTIUM through its proprietary targeted RNA sequencing tools FiMICS and BIOPRED to redefine heart failure with preserved ejection fraction (HFpEF)

  Major health stakeholders in France launch the PACIFIC Consortium to redefine heart failure with preserved ejection fraction (HFpEF) Paris (France) - January 21, 2019 - Sanofi, Servier, Medicen Paris-Region, BpiFrance, the “Secrétariat Général Pour l’Investissement”, “l’Assistance Publique– Hôpitaux de Paris”, Inserm, Bioserenity, Casis, Fealinx and Firalis announced the launch of the PACIFIC consortium (Physiopathology,…
Read more

ADDIA’s algorithms: a simple blood test for Alzheimer diagnostic

We are pleased to announce that AMONETA Diagnostics has exceeded €184k in participatory fundraising with a commitment this week from SODIV, a regional fund Grand Est. ADDIA is the first non-invasive IVD test performed on a single blood sample and will be CE and IVD certified by the end of 2019. The clinical study supported by…
Read more

Amoneta Diagnostics (a Firalis affiliate) raises funds via Crowdfunding

You can have a part of Amoneta Diagnostics via Crowdfunding operation open now ! Click here to know more. Amoneta develops a biomarker based non-invasive, simple and realiable blood test for early diagnosis of Alzheimer supported by several EU funding. As agreed by the majority of KOLs; "an efficient and simple diagnosis of Alzheimer's Disease…
Read more